A branch of medical imaging known as "Molecular Imaging" focuses on capturing images of molecules in living patients that are relevant to medicine. This contrasts with traditional techniques like histopathology for extracting molecular information from preserved tissue samples. The molecules of interest might either be those generated naturally by the body or those that a doctor injects into a patient that were created artificially in a lab. The procedure of injecting a contrast agent—such as a microbubble, metal ion, or radioactive isotope—into a patient's bloodstream and then using an imaging modality to monitor its movement within the body—such as ultrasound, MRI, CT, or PET—is the most typical example of molecular imaging used in clinical practise today. The desire to comprehend fundamental biological processes led to the development of molecular imaging in the area of radiology. The science of radiology developed molecular imaging as a non-invasive way to better comprehend basic molecular processes inside of living things. The ultimate objective of molecular imaging is the non-invasive real-time monitoring of all the biochemical activities taking on inside an organism. Cellular/molecular biology, chemistry, and medical physics are all involved in current molecular imaging research, which is focused on three main areas: 1) developing imaging methods to detect previously undetectable types of molecules; 2) increasing the number and types of contrast agents; and 3) creating functional contrast agents that provide information about the various activities that cells and tissues carry out in both health and disease.
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Rational optimization of antibody–cyanine bioconjugates for targeted theranostic drug delivery and photo/sono activation
Amartya Sanyal, Ariel University, Israel
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : From in silico design to xenograft validation: Synthesis and evaluation of an Anti-EGFR antibody-derived peptide-drug conjugate for NSCLC
Pousali Mitra, Ariel University, Israel